JP2004520292A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520292A5
JP2004520292A5 JP2002547905A JP2002547905A JP2004520292A5 JP 2004520292 A5 JP2004520292 A5 JP 2004520292A5 JP 2002547905 A JP2002547905 A JP 2002547905A JP 2002547905 A JP2002547905 A JP 2002547905A JP 2004520292 A5 JP2004520292 A5 JP 2004520292A5
Authority
JP
Japan
Prior art keywords
imidazole
alkyl
phenylethynyl
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002547905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004520292A (ja
JP4077317B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/013714 external-priority patent/WO2002046166A1/en
Publication of JP2004520292A publication Critical patent/JP2004520292A/ja
Publication of JP2004520292A5 publication Critical patent/JP2004520292A5/ja
Application granted granted Critical
Publication of JP4077317B2 publication Critical patent/JP4077317B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002547905A 2000-12-04 2001-11-26 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体 Expired - Fee Related JP4077317B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00126615 2000-12-04
PCT/EP2001/013714 WO2002046166A1 (en) 2000-12-04 2001-11-26 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007325072A Division JP2008169206A (ja) 2000-12-04 2007-12-17 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体

Publications (3)

Publication Number Publication Date
JP2004520292A JP2004520292A (ja) 2004-07-08
JP2004520292A5 true JP2004520292A5 (enExample) 2005-05-26
JP4077317B2 JP4077317B2 (ja) 2008-04-16

Family

ID=8170567

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002547905A Expired - Fee Related JP4077317B2 (ja) 2000-12-04 2001-11-26 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体
JP2007325072A Pending JP2008169206A (ja) 2000-12-04 2007-12-17 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007325072A Pending JP2008169206A (ja) 2000-12-04 2007-12-17 グルタメート受容体アンタゴニストとしてのフェニルエテニルまたはフェニルエチニル誘導体

Country Status (31)

Country Link
US (4) US6706707B2 (enExample)
EP (1) EP1349839B8 (enExample)
JP (2) JP4077317B2 (enExample)
KR (1) KR100515549B1 (enExample)
CN (1) CN1257894C (enExample)
AR (1) AR035401A1 (enExample)
AT (1) ATE288898T1 (enExample)
AU (2) AU2002229567B2 (enExample)
BG (1) BG107877A (enExample)
BR (1) BR0115871A (enExample)
CA (1) CA2430696C (enExample)
CZ (1) CZ20031795A3 (enExample)
DE (1) DE60108900T2 (enExample)
DK (1) DK1349839T3 (enExample)
EC (1) ECSP034640A (enExample)
ES (1) ES2248410T3 (enExample)
HR (1) HRP20030429A2 (enExample)
HU (1) HUP0400570A3 (enExample)
IL (2) IL155999A0 (enExample)
MA (1) MA26971A1 (enExample)
MX (1) MXPA03004862A (enExample)
NO (1) NO324326B1 (enExample)
NZ (1) NZ525917A (enExample)
PL (1) PL366222A1 (enExample)
PT (1) PT1349839E (enExample)
RS (1) RS43903A (enExample)
RU (1) RU2284323C9 (enExample)
SI (1) SI1349839T1 (enExample)
SK (1) SK8402003A3 (enExample)
WO (1) WO2002046166A1 (enExample)
ZA (1) ZA200303870B (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0128996D0 (en) * 2001-12-04 2002-01-23 Novartis Ag Organic compounds
WO2004014881A2 (en) 2002-08-09 2004-02-19 Astra Zeneca Ab '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
CN1691944A (zh) * 2002-08-09 2005-11-02 阿斯利康(瑞典)有限公司 作为代谢型谷氨酸受体-5调节剂的噁二唑
AU2003264018A1 (en) 2002-08-09 2004-02-25 Astrazeneca Ab Compounds having an activity at metabotropic glutamate receptors
ITMI20030151A1 (it) * 2003-01-30 2004-07-31 Recordati Ind Chimica E Farma Ceutica S P A Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore.
JP2006519251A (ja) 2003-03-04 2006-08-24 アデックス ファーマシューティカルズ ソシエテ アノニム mGluR5アンタゴニストとしての新規アミノピリジン誘導体
CN100516040C (zh) 2003-03-07 2009-07-22 安斯泰来制药有限公司 具有2,6-二取代苯乙烯基的含氮杂环衍生物
TWI292318B (en) 2003-03-10 2008-01-11 Hoffmann La Roche Imidazol-4-yl-ethynyl-pyridine derivatives
AU2004226450A1 (en) 2003-03-26 2004-10-14 Merck & Co. Inc. Benzamide modulators of metabotropic glutamate receptors
UA80888C2 (en) 2003-06-05 2007-11-12 Hoffmann La Roche Imidazole derivatives as glutmate receptor antagonists
US7531529B2 (en) 2003-06-05 2009-05-12 Roche Palo Alto Llc Imidazole derivatives
MXPA05013233A (es) * 2003-06-12 2006-03-09 Hoffmann La Roche Derivados de imidazol heteroaril-substituidos como antagonistas del receptor de glutamato.
ES2332184T3 (es) * 2004-03-22 2010-01-28 ELI LILLY & COMPANY Derivados de piridilo y su uso como antagonistas del receptor mglu5.
EP2261218B1 (en) * 2004-05-26 2013-04-03 Eisai R&D Management Co., Ltd. Imidazole compound for use as an intermediate in the production of cinnamide compounds
HRP20080363T3 (hr) 2004-06-01 2008-09-30 F. Hoffmann - La Roche Ag Piridin-4-il-etinil-imidazoli i pirazoli kao antagonisti mglu5 receptora
EP1756086B1 (en) * 2004-06-01 2008-06-04 F.Hoffmann-La Roche Ag Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
DE102004044884A1 (de) 2004-09-14 2006-05-24 Grünenthal GmbH Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
KR20070083781A (ko) 2004-10-26 2007-08-24 에자이 알앤드디 매니지먼트 가부시키가이샤 신나미드 화합물의 비정질체
BRPI0517423A (pt) * 2004-12-27 2008-10-07 Astrazeneca Ab composto, composição farmacêutica, método para o tratamento ou prevenção de distúrbios neurológicos e psiquiátricos associados com disfunção do glutamato em um animal, e, uso em um composto
CA2601098C (en) * 2005-03-16 2011-07-05 Aventis Pharmaceuticals Inc. Dipyrazoles as central nervous system agents
PT1863818E (pt) * 2005-03-23 2010-04-09 Hoffmann La Roche Derivados de acetilenil-pirazolo-pirimidina como antagonistas de mglur2
GB0508319D0 (en) 2005-04-25 2005-06-01 Novartis Ag Organic compounds
CA2628047A1 (en) * 2005-11-18 2007-05-24 Eisai R & D Management Co., Ltd. Process for production of cinnamide derivative
EP1953151A4 (en) * 2005-11-18 2010-06-02 Eisai R&D Man Co Ltd SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF
TWI370130B (en) 2005-11-24 2012-08-11 Eisai R&D Man Co Ltd Two cyclic cinnamide compound
TWI386207B (zh) * 2005-11-24 2013-02-21 Eisai R&D Man Co Ltd 味啉類型之肉桂醯胺化合物
JP5537033B2 (ja) * 2005-12-19 2014-07-02 ザ ユニヴァーシティー オブ リヴァプール 無痛覚
DE102005062985A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln
TWI378091B (en) 2006-03-09 2012-12-01 Eisai R&D Man Co Ltd Multi-cyclic cinnamide derivatives
GEP20115139B (en) * 2006-03-09 2011-01-10 Eisai R&D Man Co Ltd Polycyclic cinnamide derivative
DE102006011574A1 (de) * 2006-03-10 2007-10-31 Grünenthal GmbH Substituierte Imidazo[2,1-b]thiazol-Verbindungen und ihre Verwendung zur Herstellung von Arzneimitteln
SA07280403B1 (ar) * 2006-07-28 2010-12-01 إيساي أر أند دي منجمنت كو. ليمتد ملح رباعي لمركب سيناميد
AU2007336369B2 (en) 2006-12-21 2013-01-17 F. Hoffmann-La Roche Ag Polymorphs of a mGluR5 receptor antagonist
TW200848054A (en) 2007-02-28 2008-12-16 Eisai R&D Man Co Ltd Two cyclic oxomorpholine derivatives
CN101679360A (zh) * 2007-05-16 2010-03-24 卫材R&D管理有限公司 一步生产肉桂酰胺衍生物的方法
US7935815B2 (en) 2007-08-31 2011-05-03 Eisai R&D Management Co., Ltd. Imidazoyl pyridine compounds and salts thereof
AR068121A1 (es) 2007-08-31 2009-11-04 Eisai R&D Man Co Ltd Compuestos multiciclicos para tratar enfermedades neurodegenerativas
CA2712095A1 (en) * 2008-01-28 2009-08-06 Eisai R&D Management Co., Ltd. Crystalline cinnamide compounds or salts thereof
US8323805B2 (en) 2009-06-04 2012-12-04 Nitto Denko Corporation Emissive aryl-heteroaryl acetylenes
US8334287B2 (en) 2009-07-17 2012-12-18 Hoffmann-La Roche Inc. Imidazoles
WO2012015024A1 (ja) * 2010-07-29 2012-02-02 大正製薬株式会社 エチニル-ピラゾール誘導体
CA3006745C (en) 2010-11-05 2021-03-30 Oat Agrio Co., Ltd. Ethynylphenylamidine compound or salt thereof, method for producing same, and fungicide for agricultural and horticultural use
WO2012172093A1 (en) * 2011-06-17 2012-12-20 Merz Pharma Gmbh & Co. Kgaa Dihydroindolizine derivate as metabotropic glutamate receptor modulators
KR101291037B1 (ko) * 2011-10-12 2013-08-01 사회복지법인 삼성생명공익재단 레스베라트롤 유도체와 스티릴-오각형 방향족 화합물 및 이들의 베타-아밀로이드 플라그에 대한 결합제 및 진단영상제의 용도
WO2017117708A1 (en) 2016-01-05 2017-07-13 Hua Medicine (Shanghai) Ltd. Pyrazole derivatives
WO2017173604A1 (en) 2016-04-06 2017-10-12 Hua Medicine (Shanghai) Ltd. Pyrrole derivatives
TW201837026A (zh) 2017-01-10 2018-10-16 德商拜耳廠股份有限公司 作為除害劑之雜環衍生物(二)
KR20200035035A (ko) 2017-07-31 2020-04-01 노파르티스 아게 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도
US12479816B2 (en) 2019-02-08 2025-11-25 University of Pittsburgh—of the Commonwealth System of Higher Education 20-HETE formation inhibitors
CN114746408B (zh) * 2019-12-02 2025-02-14 豪夫迈·罗氏有限公司 炔基-(杂芳基)-甲酰胺hcn1抑制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3303199A (en) 1963-07-15 1967-02-07 Geigy Chem Corp Certain imidazolone derivatives and process for making same
US3341548A (en) 1964-04-29 1967-09-12 Hoffmann La Roche Nitroimidazoles and their preparation
DE2035905A1 (de) * 1970-07-20 1972-02-03 Chemische Fabrik Stockhausen & Cie.,4150Krefeld Imidazolverbindungen und deren Herstellungsverfahren
CA1174673A (en) 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
US4711962A (en) 1984-10-18 1987-12-08 Stauffer Chemical Company Process for selective preparation of ratios of isomers formed on N-substitution of asymmetric imidazoles
KR0163595B1 (ko) 1989-06-30 1998-12-01 미리암디, 메코너헤이 치환된 이미다졸
US5821937A (en) * 1996-02-23 1998-10-13 Netsuite Development, L.P. Computer method for updating a network design
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
ID28529A (id) * 1997-08-14 2001-05-31 Hoffmann La Roche Vinileter heterosiklik untuk gangguan neurologi
US6377987B1 (en) * 1999-04-30 2002-04-23 Cisco Technology, Inc. Mechanism for determining actual physical topology of network based on gathered configuration information representing true neighboring devices
JP4815083B2 (ja) * 1999-08-31 2011-11-16 メルク・シャープ・エンド・ドーム・コーポレイション 複素環化合物およびそれの使用方法

Similar Documents

Publication Publication Date Title
RU2003119548A (ru) Фенилэтенил-или фенилэтенилпроизводные в качестве антагонистов глутаматного рецептора
JP2004523535A5 (enExample)
JP2003510359A5 (enExample)
TWI268925B (en) 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
JP2005509632A5 (enExample)
IL160945A (en) 4, 5 - diarylthiazole - 2 - carboxamides having cb1 - antagonistic, agonistic or partial agonistic activity and use thereof for the preparation of pharmaceutical compositions
JP2006501201A5 (enExample)
JP2002540155A5 (enExample)
JP2005536475A5 (enExample)
RU2005131165A (ru) Производные имидазол-4-илэтинилпиридина
JP2009525340A5 (enExample)
JP2014502979A5 (enExample)
JP2007511485A5 (enExample)
JP2009514878A5 (enExample)
JP2005533835A5 (enExample)
JP2006501306A5 (enExample)
JP2004525965A5 (enExample)
JP2007502265A5 (enExample)
JP2005526696A5 (enExample)
CN102223882B (zh) 用于治疗肥厚型心肌病的III 型磷酸二酯酶(PPE III)抑制剂或Ca2+敏化剂
JP2011524896A5 (enExample)
JP2002505286A5 (enExample)
JP2004521150A5 (enExample)
JP2004524279A5 (enExample)
JP2004520424A5 (enExample)